Redcare Pharmacy NV
RDC
Company Profile
Business description
Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue from the DACH segment, which represents income generated from Germany, Austria, and Switzerland. The International segment represents its income generated from Belgium, the Netherlands, France, and Italy.
Contact
Erik de Rodeweg 11/13
SevenumZH5975 WD
NLDT: +31 800200800
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2026
Employees
2,266
Stocks News & Analysis
stocks
ASX player rallies on small guidance upgrade
Our fair value is maintained despite investor enthusiasm.
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
With strong fourth-quarter earnings and AI integration, here’s what we think of Alphabet stock.
stocks
Cisco earnings: AI orders and profitability look strong despite second-half choppiness
We’ve raised our fair value estimate of Cisco stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,189.20 | 16.20 | -0.18% |
| CAC 40 | 8,340.56 | 27.32 | 0.33% |
| DAX 40 | 24,852.69 | 3.46 | -0.01% |
| Dow JONES (US) | 49,694.37 | 427.03 | -0.85% |
| FTSE 100 | 10,402.44 | 69.67 | -0.67% |
| HKSE | 27,032.54 | 233.84 | -0.86% |
| NASDAQ | 22,726.81 | 339.66 | -1.47% |
| Nikkei 225 | 57,639.84 | 10.70 | -0.02% |
| NZX 50 Index | 13,427.44 | 79.84 | -0.59% |
| S&P 500 | 6,872.16 | 69.31 | -1.00% |
| S&P/ASX 200 | 8,965.50 | 7.40 | -0.08% |
| SSE Composite Index | 4,134.02 | 2.03 | 0.05% |